Page 114 - AN-4-3

Advanced Neurology ADRD comorbidities and senescence

in Alzheimer’s disease: A nested case-control study. world data. Neurology. 2024;102(17_Suppl_1).
J Alzheimers Dis. 2018;63(2):773-781.
doi: 10.1212/WNL.0000000000205454
doi: 10.3233/JAD-170786
16. Gonzales MM, Garbarino VR, Marques Zilli E, et al.
6. Doraiswamy PM, Leon J, Cummings JL, Marin D, Neumann PJ. Senolytic therapy to modulate the progression of Alzheimer’s
Prevalence and impact of medical comorbidity in disease (SToMP-AD): A pilot clinical trial. J Prev Alzheimers
Alzheimer’s disease. J Gerontol A Biol Sci Med Sci. Dis. 2022;9(1):22-29.
2002;57(3):M173-M177.
doi: 10.14283/jpad.2021.62
doi: 10.1093/gerona/57.3.m173
17. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C.
7. Mielke MM, Dage JL, Frank RD, et al. Performance of Potential for primary prevention of Alzheimer’s disease:
plasma phosphorylated tau 181 and 217 in the community. An analysis of population-based data. Lancet Neurol.
Nat Med. 2022;28(7):1398-1405. 2014;13(8):788-794.
doi: 10.1038/s41591-022-01822-2 doi: 10.1016/S1474-4422(14)70136-X. Erratum in: Lancet
8. McCormick WC, Kukull WA, van Belle G, Bowen JD, Neurol. 2014;13(11):1070.
Teri L, Larson EB. Symptom patterns and comorbidity in 18. Livingston G, Sommerlad A, Orgeta V, et al.
the early stages of Alzheimer’s disease. J Am Geriatr Soc. Dementia prevention, intervention, and care. Lancet.
1994;42(5):517-521. 2017;390(10113):2673-2734.
doi: 10.1111/j.1532-5415.1994.tb04974.x doi: 10.1016/S0140-6736(17)31363-6
9. Fereshtehnejad SM, Damangir S, Cermakova P, Aarsland D, 19. Livingston G, Huntley J, Sommerlad A, et al. Dementia
Eriksdotter M, Religa D. Comorbidity profile in dementia prevention, intervention, and care: 2020 report of the lancet
with Lewy bodies versus Alzheimer’s disease: A linkage commission. Lancet. 2020;396(10248):413-446.
study between the Swedish Dementia Registry and the
Swedish National Patient Registry. Alzheimers Res Ther. doi: 10.1016/S0140-6736(20)30367-6
2014;6(5-8):65. 20. Yaffe K, Vittinghoff E, Dublin S, et al. Effect of personalized
doi: 10.1186/s13195-014-0065-2 risk-reduction strategies on cognition and dementia risk
profile among older adults: The SMARRT randomized
10. Jørgensen IF, Aguayo-Orozco A, Lademann M, Brunak S. clinical trial. JAMA Intern Med. 2024;184(1):54-62.
Age-stratified longitudinal study of Alzheimer’s and vascular
dementia patients. Alzheimers Dement. 2020;16:908-917. doi: 10.1001/jamainternmed.2023.6279
doi: 10.1002/alz.12091 21. Lai SW, Lin CL, Liao KF. Cataract may be a non-memory
feature of Alzheimer’s disease in older people. Eur J
11. Melis RJ, Marengoni A, Rizzuto D, et al. The influence of Epidemiol. 2014;29(6):405-409.
multimorbidity on clinical progression of dementia in a
population-based cohort. PLoS One. 2013;8:e84014. doi: 10.1007/s10654-014-9903-6
doi: 10.1371/journal.pone.0084014 22. Shang X, Zhu Z, Huang Y, et al. Associations of ophthalmic
and systemic conditions with incident dementia in the UK
12. Haaksma ML, Vilela LR, Marengoni A, et al. Comorbidity Biobank. Br J Ophthalmol. 2023;107(2):275-282.
and progression of late onset Alzheimer’s disease: A
systematic review. PLoS One. 2017;12:e0177044. doi: 10.1136/bjophthalmol-2021-319508
doi: 10.1371/journal.pone.0177044 23. Ma LZ, Zhang YR, Li YZ, et al. Cataract, cataract surgery,
and risk of incident dementia: A prospective cohort study of
13. Hill NL, Bhargava S, Brown MJ, et al. Cognitive complaints 300,823 participants. Biol Psychiatry. 2023;93(9):810-819.
in age-related chronic conditions: A systematic review. PLoS
One. 2021;16(7):e0253795. doi: 10.1016/j.biopsych.2022.06.005
doi: 10.1371/journal.pone.0253795 24. Lee CS, Gibbons LE, Lee AY, et al. Association between
cataract extraction and development of dementia. JAMA
14. Rajamaki B, Hartikainen S, Tolppanen AM. The effect of Intern Med. 2022;182(2):134-141.
comorbidities on survival in persons with Alzheimer’s
disease: A matched cohort study. BMC Geriatr. 2021; doi: 10.1001/jamainternmed.2021.6990
21(1):173.
25. Hokkinen K, Kaarniranta K, Jämsen E, Lampela P,
doi: 10.1186/s12877-021-02130-z Hartikainen S, Tolppanen AM. Incidence of cataract
surgeries in people with and without Alzheimer’s disease.
15. Peroutka SJ, Lledó-Macau A. Age demographics of
Alzheimer’s disease clinical trial subjects compared to Acta Ophthalmol. 2022;100(1):68-73.
Alzheimer’s disease and related dementia patients from real doi: 10.1111/aos.14896

Volume 4 Issue 3 (2025) 108 doi: 10.36922/an.4046